These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28852930)

  • 1. Role of SH3b binding domain in a natural deletion mutant of Kayvirus endolysin LysF1 with a broad range of lytic activity.
    Benešík M; Nováček J; Janda L; Dopitová R; Pernisová M; Melková K; Tišáková L; Doškař J; Žídek L; Hejátko J; Pantůček R
    Virus Genes; 2018 Feb; 54(1):130-139. PubMed ID: 28852930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells.
    Becker SC; Dong S; Baker JR; Foster-Frey J; Pritchard DG; Donovan DM
    FEMS Microbiol Lett; 2009 May; 294(1):52-60. PubMed ID: 19493008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain.
    Becker SC; Foster-Frey J; Stodola AJ; Anacker D; Donovan DM
    Gene; 2009 Aug; 443(1-2):32-41. PubMed ID: 19422893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K.
    Sanz-Gaitero M; Keary R; Garcia-Doval C; Coffey A; van Raaij MJ
    Virol J; 2014 Jul; 11():133. PubMed ID: 25064136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lytic activity of the staphylolytic Twort phage endolysin CHAP domain is enhanced by the SH3b cell wall binding domain.
    Becker SC; Swift S; Korobova O; Schischkova N; Kopylov P; Donovan DM; Abaev I
    FEMS Microbiol Lett; 2015 Jan; 362(1):1-8. PubMed ID: 25790497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage.
    Fujiki J; Nakamura T; Furusawa T; Ohno H; Takahashi H; Kitana J; Usui M; Higuchi H; Tanji Y; Tamura Y; Iwano H
    Pharmaceuticals (Basel); 2018 Feb; 11(1):. PubMed ID: 29495305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site.
    Abaev I; Foster-Frey J; Korobova O; Shishkova N; Kiseleva N; Kopylov P; Pryamchuk S; Schmelcher M; Becker SC; Donovan DM
    Appl Microbiol Biotechnol; 2013 Apr; 97(8):3449-56. PubMed ID: 22777279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of staphylococcal endolysin LysSAP33 possessing untypical domain composition.
    Yu JH; Park DW; Lim JA; Park JH
    J Microbiol; 2021 Sep; 59(9):840-847. PubMed ID: 34383247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.
    Schmelcher M; Powell AM; Becker SC; Camp MJ; Donovan DM
    Appl Environ Microbiol; 2012 Apr; 78(7):2297-305. PubMed ID: 22286996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LysPBC2, a Novel Endolysin Harboring a Bacillus cereus Spore Binding Domain.
    Kong M; Na H; Ha NC; Ryu S
    Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30552194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci.
    Gu J; Lu R; Liu X; Han W; Lei L; Gao Y; Zhao H; Li Y; Diao Y
    Curr Microbiol; 2011 Dec; 63(6):538-42. PubMed ID: 21947237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus.
    Linden SB; Zhang H; Heselpoth RD; Shen Y; Schmelcher M; Eichenseher F; Nelson DC
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):741-52. PubMed ID: 25038926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin.
    Donovan DM; Lardeo M; Foster-Frey J
    FEMS Microbiol Lett; 2006 Dec; 265(1):133-9. PubMed ID: 17054440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'.
    Schmelcher M; Korobova O; Schischkova N; Kiseleva N; Kopylov P; Pryamchuk S; Donovan DM; Abaev I
    J Biotechnol; 2012 Dec; 162(2-3):289-98. PubMed ID: 23026556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein.
    Paul VD; Rajagopalan SS; Sundarrajan S; George SE; Asrani JY; Pillai R; Chikkamadaiah R; Durgaiah M; Sriram B; Padmanabhan S
    BMC Microbiol; 2011 Oct; 11():226. PubMed ID: 21985151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan.
    Sundarrajan S; Raghupatil J; Vipra A; Narasimhaswamy N; Saravanan S; Appaiah C; Poonacha N; Desai S; Nair S; Bhatt RN; Roy P; Chikkamadaiah R; Durgaiah M; Sriram B; Padmanabhan S; Sharma U
    Microbiology (Reading); 2014 Oct; 160(Pt 10):2157-2169. PubMed ID: 25023246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel cell wall binding domain-containing Staphylococcus aureus endolysin LysSA97.
    Chang Y; Ryu S
    Appl Microbiol Biotechnol; 2017 Jan; 101(1):147-158. PubMed ID: 27498125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk.
    Obeso JM; Martínez B; Rodríguez A; García P
    Int J Food Microbiol; 2008 Dec; 128(2):212-8. PubMed ID: 18809219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizations of the endolysin Lys84 and its domains from phage qdsa002 with high activities against Staphylococcus aureus and its biofilms.
    Ning H; Lin H; Wang J; He X; Lv X; Ju L
    Enzyme Microb Technol; 2021 Aug; 148():109809. PubMed ID: 34116743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Domain Manipulation in the Staphylococcal Phage Endolysin, Endo88, on Lytic Efficiency and Host Range.
    Krishnan M; Tham HY; Wan Nur Ismah WAK; Yusoff K; Song AA
    Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38904894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.